Our scientific team have 30+ years’ expertise in the development and screening of in vitro biochemical and cell-based screening assays (biochemical/cellular/HCA), coupled to proprietary fragment and small molecule screening libraries. We have a proven track record in the use of disease-relevant cellular models, incl. iPSCs for (immuno-) oncology, immunology, dermatology, neurology, metabolic diseases and cardiology, to get insights into the Mode-of-Action of your compound.